We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WELL icon
651
Welltower
WELL
$170B
$173K 0.01%
2,114
-5,608
-73% -$480K
TEVA icon
652
Teva Pharmaceuticals
TEVA
$40.6B
$172K 0.01%
17,582
+17,229
+4,881% +$154K
CCK icon
653
Crown Holdings
CCK
$13.2B
$170K 0.01%
2,335
+2,233
+2,189% +$159K
HUYA
654
Huya Inc
HUYA
$554M
$170K 0.01%
9,465
+7,840
+482% +$166K
SF
655
Stifel
SF
$12.6B
$170K 0.01%
6,291
+4,196
+200% +$110K
ISBC
656
DELISTED
Investors Bancorp, Inc.
ISBC
$170K 0.01%
14,292
+6,993
+96% +$83.8K
PM icon
657
Philip Morris
PM
$293B
$169K 0.01%
1,992
-19,421
-91% -$1.6M
KWEB icon
658
KraneShares CSI China Internet ETF
KWEB
$5.62B
$168K 0.01%
+3,457
New +$158K
MGV icon
659
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.4B
$168K 0.01%
1,922
-6,972
-78% -$585K
OMF icon
660
OneMain Financial
OMF
$7.48B
$168K 0.01%
3,975
+3,486
+713% +$141K
ZD icon
661
Ziff Davis
ZD
$1.88B
$168K 0.01%
2,056
+1,020
+98% +$84.3K
AZN icon
662
AstraZeneca
AZN
$250B
$167K 0.01%
1,679
-4,017
-71% -$378K
NDAQ icon
663
Nasdaq
NDAQ
$52.9B
$167K 0.01%
4,689
-7,266
-61% -$248K
SAP icon
664
SAP
SAP
$230B
$167K 0.01%
1,244
+282
+29% +$37.1K
WERN icon
665
Werner Enterprises
WERN
$2.21B
$167K 0.01%
4,594
+4,247
+1,224% +$155K
KURA icon
666
Kura Oncology
KURA
$824M
$166K 0.01%
12,035
+9,066
+305% +$134K
SA
667
Seabridge Gold
SA
$3.12B
$166K 0.01%
12,053
+3,569
+42% +$45.2K
SVC
668
Service Properties Trust
SVC
$1.09B
$166K 0.01%
1,364
+1,048
+332% +$128K
UBIO
669
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
$166K 0.01%
5,075
-8,839
-64% -$235K
CGC
670
Canopy Growth
CGC
$394M
$165K 0.01%
783
+251
+47% +$49.8K
ROK icon
671
Rockwell Automation
ROK
$49.1B
$165K 0.01%
813
-3,098
-79% -$574K
MAXR
672
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$165K 0.01%
10,596
-4,595
-30% -$47.7K
HRB icon
673
H&R Block
HRB
$5.82B
$164K 0.01%
6,994
-172
-2% -$4.13K
MYGN icon
674
Myriad Genetics
MYGN
$304M
$164K 0.01%
+6,039
New +$166K
AKCA
675
DELISTED
Akcea Therapeutics Inc
AKCA
$164K 0.01%
+9,672
New +$180K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.